Stockscreener 앱 받기
15.43
2.59%
-0.41
시간 외 거래:
14.93
-0.50
-3.24%
전일 마감가:
$15.84
열려 있는:
$15.68
하루 거래량:
224.34K
Relative Volume:
1.03
시가총액:
$822.37M
수익:
-
순이익/손실:
$-83.74M
주가수익비율:
-9.5839
EPS:
-1.61
순현금흐름:
$-64.98M
1주 성능:
+3.98%
1개월 성능:
+12.96%
6개월 성능:
+42.08%
1년 성능:
-5.86%
1일 변동 폭
$14.83
$15.99
1주일 범위
$14.32
$16.05
52주 변동 폭
$6.42
$17.78
Tyra Biosciences Inc Stock (TYRA) Company Profile
명칭
Tyra Biosciences Inc
전화
(619) 728-4760
주소
2656 STATE STREET, CARLSBAD
TYRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
15.43 | 844.23M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-05-21 | 재개 | Piper Sandler | Overweight |
| 2025-01-07 | 개시 | UBS | Buy |
| 2024-10-18 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-08-15 | 개시 | Piper Sandler | Overweight |
| 2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-30 | 개시 | Wedbush | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-06-23 | 개시 | H.C. Wainwright | Buy |
| 2022-03-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-11-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Jefferies | Buy |
모두보기
Tyra Biosciences Inc 주식(TYRA)의 최신 뉴스
Tyra Biosciences Inc expected to post a loss of 50 cents a shareEarnings Preview - TradingView
Is Tyra Biosciences Inc. stock supported by strong fundamentalsWeekly Investment Report & Weekly Top Gainers Alerts - newser.com
Risk vs reward if holding onto Tyra Biosciences Inc.July 2025 Highlights & Low Risk Investment Opportunities - newser.com
Has Tyra Biosciences Inc. found a price floorJuly 2025 Weekly Recap & Daily Profit Focused Stock Screening - newser.com
Does Tyra Biosciences Inc. fit your quant trading modelQuarterly Performance Summary & Expert-Curated Trade Recommendations - newser.com
How Tyra Biosciences Inc. stock performs during Fed tightening cyclesPortfolio Return Summary & Safe Entry Momentum Tips - newser.com
Will Tyra Biosciences Inc. stock rally after Fed decisionsTrade Entry Report & High Conviction Trade Alerts - newser.com
Is Tyra Biosciences Inc. stock attractive for long term wealth building2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Will Tyra Biosciences Inc. continue its uptrend2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Can technical indicators confirm Tyra Biosciences Inc.’s reversalPortfolio Return Report & Entry and Exit Point Strategies - newser.com
What’s the recovery path for long term holders of Tyra Biosciences Inc.Quarterly Trade Summary & Risk Managed Investment Signals - newser.com
Is Tyra Biosciences Inc. stock poised for growthTrend Reversal & Reliable Entry Point Alerts - newser.com
Historical volatility pattern of Tyra Biosciences Inc. visualizedEarnings Miss & Expert Verified Movement Alerts - newser.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Heatmap analysis for Tyra Biosciences Inc. and competitorsEarnings Beat & Accurate Technical Buy Alerts - newser.com
Tyra Biosciences (TYRA) Projected to Post Earnings on Thursday - MarketBeat
Signal strength of Tyra Biosciences Inc. stock in tech scanners2025 Performance Recap & High Conviction Investment Ideas - newser.com
AlphaQuest LLC Has $699,000 Stock Holdings in Tyra Biosciences, Inc. $TYRA - MarketBeat
Tyra Biosciences backs cancer forum to advance urologic oncology - Traders Union
Tyra Biosciences Inc (TYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):